01.22.2008 11:37 am
KV buys premature birth treatment drug for $82 million
St. Louis Post-Dispatch
KV Pharmaceutical Co., based in Brentwood, said today it is paying $82 million for exclusive worldwide rights to sell Gestiva, a preventive treatment for premature birth that is awaiting regulatory approval.
KV said it is paying Bedford, Mass.-based Hologic Inc. $7.5 million as the…
